5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential

  • Posted on June 25, 2025
  • By Financial Express
  • 3 Views
5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential

Explore Goldman Sachs' top 5 Indian pharma stock picks with up to 36% upside - see the full recommendations now!
continue reading...

Author
Financial Express

You May Also Like